NasdaqGS:HALOBiotechs
Insiders at Halozyme Therapeutics, Inc. (NASDAQ:HALO) sold US$2.7m worth of stock, a potential red flag that needs to be monitored
While it’s been a great week for Halozyme Therapeutics, Inc. ( NASDAQ:HALO ) shareholders after stock gained 11%, they...